R5	Coref Anaphora:T31 Antecedent:T48
R6	Coref Anaphora:T34 Antecedent:T49
R7	Coref Anaphora:T38 Antecedent:T42
T50	SPAN 944 957	JunD or c-Fos
R8	Coref Anaphora:T41 Antecedent:T50
T1	Protein 4 17	interleukin-8
T2	Protein 306 319	interleukin-8
T3	Protein 321 325	IL-8
T4	Protein 497 501	IL-8
T5	Protein 944 948	JunD
T6	Protein 952 957	c-Fos
T7	Protein 1167 1172	c-Rel
T8	Protein 1174 1177	p65
T9	Protein 1179 1182	p50
T10	Protein 1188 1191	p49
T11	Protein 1437 1441	IL-8
T12	Protein 1464 1474	Ig kappa B
T13	Protein 1595 1599	IL-2
T14	Protein 1600 1605	NF-AT
T15	Protein 1610 1617	NFIL-2A
T16	Protein 1628 1638	Ig kappa B
T17	Protein 1658 1662	IL-8
T48	Exp 873 910	PMA/ionomycin-induced nuclear factors
T49	Exp 1053 1082	B-like site binding complexes
T21	Exp 0 22	The interleukin-8 AP-1
T22	Exp 173 187	the production
T23	Exp 227 229	We
T24	Exp 239 243	that
T25	Exp 261 278	the transcription
T26	Exp 493 511	the IL-8 promoters
T27	Exp 513 521	the AP-1
T28	Exp 564 587	the responsive elements
T29	Exp 628 646	the transcriptions
T30	Exp 655 663	the AP-1
T31	Exp 912 917	which
T32	Exp 841 852	the binding
T33	Exp 856 869	the AP-1 site
T34	Exp 1084 1089	which
T35	Exp 1030 1043	the formation
T36	Exp 1136 1165	the human Rel family proteins
T37	Exp 1207 1209	we
T38	Exp 1240 1244	that
T39	Exp 1362 1367	which
T40	Exp 1427 1431	that
T41	Exp 1432 1436	both
T42	Exp 1220 1239	the previous report
T43	Exp 1262 1298	the PMA/ionomycin-induced activation
T44	Exp 1512 1526	the difference
T45	Exp 1547 1558	Our results
T46	Exp 1568 1572	that
T47	Exp 1654 1667	the IL-8 AP-1
